Literature DB >> 10709728

Glucose metabolism is elevated and vascular resistance and maternofetal transfer is normal in perfused placental cotyledons from severely growth-restricted fetuses.

D E Challis1, C D Pfarrer, J W Ritchie, G Koren, S L Adamson.   

Abstract

We hypothesized that placental resistance was elevated and transfer reduced in cotyledons from intrauterine growth-restricted (IUGR) fetuses. We perfused 10 cotyledons from term, normally grown fetuses, six from preterm, normally grown fetuses with normal umbilical arterial end-diastolic velocities (EDV), and six from preterm IUGR fetuses (<3rd centile) with absent or reversed umbilical arterial EDV. Perfused cotyledons were pressure-fixed, and villi were observed by scanning electron microscopy. The groups did not differ in fetoplacental resistance at baseline; neither did they differ in the change in resistance that followed the administration of nitroglycerin or angiotensin II. The increase in resistance during hypoxia was similar in the two preterm groups but greater in the term than in the preterm normally grown group (p < 0.05). Groups did not differ in net maternofetal transfer of oxygen or glucose, or in clearance of aminoisobutyric acid or antipyrine. However, glucose consumption was doubled in cotyledons of preterm IUGR versus preterm normally grown fetuses (p < 0.05). Terminal villi of perfused cotyledons from preterm IUGR fetuses displayed less terminal villous branching and budding than preterm controls, as anticipated from previous work. IUGR fetuses with absent or reversed umbilical arterial EDV in vivo may have high placental resistance due to a vasoconstrictive rather than anatomic abnormality and an elevated placental glucose consumption that may impair glucose transfer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709728     DOI: 10.1203/00006450-200003000-00005

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation.

Authors:  K Brown; D S Heller; S Zamudio; N P Illsley
Journal:  Placenta       Date:  2011-10-14       Impact factor: 3.481

2.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

3.  Considering intrauterine location in a model of fetal growth restriction after maternal titanium dioxide nanoparticle inhalation.

Authors:  J N D'Errico; S B Fournier; P A Stapleton
Journal:  Front Toxicol       Date:  2021-03-23

Review 4.  Transplacental Nutrient Transport Mechanisms of Intrauterine Growth Restriction in Rodent Models and Humans.

Authors:  Elke Winterhager; Alexandra Gellhaus
Journal:  Front Physiol       Date:  2017-11-27       Impact factor: 4.566

5.  The chinchilla as a novel animal model of pregnancy.

Authors:  Emmeli Mikkelsen; Henrik Lauridsen; Per Mose Nielsen; Haiyun Qi; Thomas Nørlinger; Maria Dahl Andersen; Niels Uldbjerg; Christoffer Laustsen; Puk Sandager; Michael Pedersen
Journal:  R Soc Open Sci       Date:  2017-04-26       Impact factor: 2.963

6.  Early restriction of placental growth results in placental structural and gene expression changes in late gestation independent of fetal hypoxemia.

Authors:  Song Zhang; Paige Barker; Kimberley J Botting; Claire T Roberts; Christine M McMillan; Isabella Caroline McMillen; Janna L Morrison
Journal:  Physiol Rep       Date:  2016-12

7.  Deuterium Magnetic Resonance Imaging and the Discrimination of Fetoplacental Metabolism in Normal and L-NAME-Induced Preeclamptic Mice.

Authors:  Stefan Markovic; Tangi Roussel; Michal Neeman; Lucio Frydman
Journal:  Metabolites       Date:  2021-06-10

8.  Diabetic and metabolic programming: mechanisms altering the intrauterine milieu.

Authors:  Claudia Eberle; Christoph Ament
Journal:  ISRN Pediatr       Date:  2012-11-20

9.  Ex Vivo Human Placenta Perfusion, Metabolic and Functional Imaging for Obstetric Research-A Feasibility Study.

Authors:  Katrine Elbæk Madsen; Christian Østergaard Mariager; Christina S Duvald; Esben Søvsø Szocska Hansen; Lotte Bonde Bertelsen; Michael Pedersen; Lars Henning Pedersen; Niels Uldbjerg; Christoffer Laustsen
Journal:  Tomography       Date:  2019-12

10.  Differential Expression of Glucose Transporter Proteins GLUT-1, GLUT-3, GLUT-8 and GLUT-12 in the Placenta of Macrosomic, Small-for-Gestational-Age and Growth-Restricted Foetuses.

Authors:  Paweł Jan Stanirowski; Dariusz Szukiewicz; Agata Majewska; Mateusz Wątroba; Michał Pyzlak; Dorota Bomba-Opoń; Mirosław Wielgoś
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.